Moreover, our PDX model with engrafted leukemic cells from a PPM1D-mutated t-AML sample provides further supportive evidence that PPM1D mutants can comprise a significant portion of diseased cells and may play a role in progression to leukemogenesis at least in some cases. The gene discussed is PPM1D; the disease is acute myeloid leukemia.